INTERNATIONAL PATENT: BRIDGENE BIOSCIENCES LIMITED FILES APPLICATION FOR "CBL-B INHIBITOR AND USES THEREOF"

GENEVA, Feb. 3 -- BRIDGENE BIOSCIENCES LIMITED (ROOM 1605, HO KING COMMERCIAL CENTRE, 2-16 FA YUEN STREET, MONGKOK, KOWLOONKowloon, Hong Kong) filed a patent application (PCT/IB2025/057485) for "CBL-B INHIBITOR AND USES THEREOF" on Jul 23, 2025. With publication no. WO/2026/022742, the details related to the patent application was published on Jan 29, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LUO, Zhushou (C/O BridGene Biosciences Inc, 75 Nicholson LnSan Jose, California 95134), JANSA, Petr (C/O BridGene Biosciences Inc, 75 Nicholson LnSan Jose, California 95134), ZHANG, Chao (C/O Brid...